Angelica Tiotiu, Claire Poreaux, Pascal Poncet, Hélène Senechal, J.L. Schmutz. Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment?.
European Journal of Dermatology , 2019, 29 (1), pp.101-2.
⟨10.1684/ejd.2018.3454⟩.
⟨pasteur-03718435⟩